Clinical trial

Acute Labetalol Use in Preeclampsia

NCT03872336

StatusTERMINATED

Study typeINTERVENTIONAL

Start date2019-02-18

PhasePHASE4

Study timeline

Study start (actual)2019-02-18Date precision: day

Registry last updated2020-07-22

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Preeclampsia With Severe Featuresunresolved

Interventions

Experimental labetalol doseDRUG

Current standard of careOTHER

Sponsors & collaborators

Albany Medical Collegelead sponsor

Mapped research locations

AlbanyNew York, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT03872336 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.